Integrated Evaluation of Phytochemical Composition, Antimicrobial, Antioxidant Potential, and Molecular Docking Studies of Rhododendron

Abstract

A particularly dangerous and aggressive kind of brain cancer with few effective treatments is glioblastoma, recently, increased attention has been paid to natural chemicals as potential sources of cutting-edge anti-cancer medications. Rhododendron, a plant known for its wide range of phytochemicals, has shown potential as a therapeutic agent for a number of diseases. The goal of this study was to employ molecular docking studies to examine the phytochemical components of Rhododendron and evaluate any potential interactions with proteins associated with glioblastoma cancer.